Sourced from:Manufacturer Authorized Distributor
Quick Summary
Tecentriq 840mg Injection
Last updated on 09 Nov 2026 | 04:44 AM (IST)
₹213786
MRP: ₹237540
(You Save ₹23754)
1 VIAL(s) OF 14ML
Sourced from:Manufacturer Authorized Distributor
Tecentriq 840mg Injection
Salt Composition
ATEZOLIZUMABPAP Offer
Contact us for latest updates.
Marketer
ROCHE PRODUCTS INDIA PVT LTD
Prepaid Only. Non-Returnable.
10% OFF
₹213786
MRP: ₹2,37,540.00
Inclusive of all taxes
10% Off
Salt Composition
ATEZOLIZUMABPAP Offer
Contact us for latest updates.
Marketer
ROCHE PRODUCTS INDIA PVT LTD
Prepaid Only. Non-Returnable.
Dispatch: Today
Care delivered without the wait. Your order is prioritized for rapid dispatch to ensure it reaches your doorstep on time.
Better Service Satisfied Customers
Introduction
Tecentriq 840mg Injection contains Atezolizumab as its active ingredient. It is a prescription medicine administered by intravenous infusion under medical supervision.
Uses of Tecentriq 840mg Injection
Tecentriq 840mg Injection may be prescribed for certain cancers, including selected:
Non-small cell lung cancer
Small cell lung cancer
Hepatocellular carcinoma
Other cancers for which Atezolizumab is approved as part of a specific treatment regimen
The exact use depends on the cancer type, stage, biomarker findings and other medicines being used.
How Tecentriq 840mg Injection Works
Tecentriq 840mg Injection contains Atezolizumab, which blocks PD-L1, a protein involved in cancer's ability to evade immune attack.
By blocking PD-L1, Atezolizumab helps restore immune-cell activity against cancer cells.
Interaction of Tecentriq 840mg Injection with Other Medicines
Tell your doctor about all prescription medicines, over-the-counter medicines, vitamins and herbal supplements you take.
Tell your oncologist about other cancer medicines or immunotherapies.
Tell your doctor if you take corticosteroids or other medicines that suppress the immune system.
Inform your healthcare team about any medicines used after an organ transplant.
Do not start or stop medicines without medical advice.
Storage Conditions
Store at 2°C to 8°C in a refrigerator.
Keep the vial in its original carton and protect it from light.
Do not freeze.
Do not shake.
How to Use
Tecentriq 840mg Injection is given intravenously by a healthcare professional.
The 840mg strength is used in treatment schedules where an 840mg dose is prescribed, including certain regimens given once every 2 weeks. The exact dose and treatment duration depend on the indication.
Safety Advice
Pregnancy
Atezolizumab may cause fetal harm. Tell your doctor if you are pregnant or planning pregnancy.
Breast Feeding
Breastfeeding is not recommended during treatment unless specifically advised by your doctor.
Lungs
Report new or worsening cough, breathing difficulty or chest discomfort immediately.
Liver
Liver inflammation can occur. Liver function may be monitored during treatment.
Alcohol
No specific direct interaction has been established, but alcohol may worsen some treatment-related symptoms.
Driving
Avoid driving if fatigue, dizziness or other treatment-related symptoms affect your concentration or reactions.
Side Effects
Common side effects
Fatigue
Reduced appetite
Nausea
Cough
Shortness of breath
Diarrhoea
Constipation
Rash
Muscle or joint pain
Serious side effects
Immune-mediated pneumonitis
Immune-mediated hepatitis
Severe diarrhoea or colitis
Immune-mediated kidney inflammation
Serious endocrine disorders
Severe skin reactions
Serious infusion-related reactions
Tecentriq can cause immune-mediated inflammation affecting different organs. These reactions may require treatment interruption or discontinuation.
Expert Tips
Attend regular blood tests and follow-up appointments.
Report new symptoms rather than waiting for your next treatment cycle.
Tell every healthcare professional that you are receiving immunotherapy.
Carry your current medicine list with you.
Discuss vaccination with your oncology team before receiving vaccines.
FAQs
Q1.
What is Tecentriq 840mg Injection used for?
It is used for selected cancers, including certain lung cancers and other approved cancers.
Q2.
How is Tecentriq 840mg Injection administered?
It is administered into a vein as an intravenous infusion by a healthcare professional.
Q3.
How often is Tecentriq 840mg Injection given?
An 840mg dose may be given every 2 weeks in certain treatment regimens. Your oncologist will decide the schedule.
Q4.
Can Tecentriq 840mg Injection cause lung problems?
Yes. Immune-mediated pneumonitis can occur and may cause cough or breathing difficulty.
Q5.
Does Tecentriq 840mg Injection affect the immune system?
Yes. It helps activate the immune response against cancer by blocking PD-L1.
Q6.
Can I receive vaccines during Tecentriq treatment?
Discuss all vaccinations with your doctor before receiving them.
Q7.
Can Tecentriq 840mg Injection be used during pregnancy?
It may harm the developing baby. Tell your doctor if you are pregnant or may become pregnant.
Q8.
Can I breastfeed during treatment?
Breastfeeding is generally not recommended during treatment. Follow your doctor's advice.
Fact Box
Molecule name: | Atezolizumab |
Therapeutic class: | Anticancer immunotherapy |
Pharmacological class: | PD-L1 inhibitor monoclonal antibody |
Indications: | Selected cancers including non-small cell lung cancer, small cell lung cancer and hepatocellular carcinoma |
References
Disclaimer
MrMed’s primary intention is to ensure that its consumers get information that is reviewed by experts, accurate and trustworthy. The information and contents of this website are for informational purposes only. They are not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of your doctor and discuss all your queries related to any disease or medicine. Do not disregard professional medical advice or delay in seeking it because of something you have read on MrMed. Our mission is to support, not replace, the doctor-patient relationship.
Did you find this information helpful?
Author Details
Written By
Vishishta
M.Sc Microbiology

Reviewed By
Dr. Tejashwin Adiga
MBBS
Last updated : 09 Nov 2026 | 04:44 AM (IST)

Want to know more?
Read Our Editorial Policy








